Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Chiocca, E.
Item TypeName
Academic Article Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses.
Academic Article The host response to cancer virotherapy.
Academic Article Personalizing oncolytic virotherapy?
Academic Article Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses.
Academic Article Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses.
Academic Article Pharmacologic and chemical adjuvants in tumor virotherapy.
Academic Article Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
Academic Article "Infectious" optimism for treatment of hepatocellular carcinoma.
Academic Article Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus.
Academic Article Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61.
Academic Article The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.
Academic Article Oncolytic viruses: extreme treatment for an extreme disease.
Academic Article Oncolytic viruses driven by tumor-specific promoters.
Academic Article Gene therapy for glioblastoma.
Academic Article Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.
Academic Article Gene and viral therapy for glioblastoma: a review of clinical trials and future directions.
Academic Article Gene therapeutics: the future of brain tumor therapy?
Academic Article Directing systemic oncolytic viral delivery to tumors via carrier cells.
Academic Article Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors.
Academic Article Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.
Academic Article Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy.
Academic Article Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16.
Academic Article Design and application of oncolytic HSV vectors for glioblastoma therapy.
Academic Article "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.
Academic Article Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.
Academic Article NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors.
Concept Oncolytic Virotherapy
Academic Article STAT3 activation promotes oncolytic HSV1 replication in glioma cells.
Academic Article Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSV.
Academic Article The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.
Academic Article DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas.
Academic Article Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.
Academic Article Modification of HSV-1 to an oncolytic virus.
Academic Article Glioma virus therapies between bench and bedside.
Academic Article Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults.
Academic Article Oncolytic viruses and their application to cancer immunotherapy.
Academic Article Oncolytic viruses targeting tumor stem cells.
Academic Article Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.
Academic Article Oncolytic virotherapy for gliomas: steps toward the future.
Academic Article Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection.
Academic Article Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.
Academic Article In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.
Academic Article TGFß Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response.
Academic Article Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV.
Academic Article Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy.
Academic Article A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.
Academic Article Oncolytic Viruses in Cancer Treatment: A Review.
Academic Article Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.
Academic Article Immunotherapy for glioblastoma: going viral.
Academic Article Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.
Academic Article Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
Academic Article Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses.
Academic Article Redesigned reporter gene for improved proton exchange-based molecular MRI contrast.
Academic Article Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells.
Search Criteria
  • Oncolytic Virotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.